Search NASA⌕ Search

SEARCH · Search NASA

Results for “Animation”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 397 records · Page 22

Risk management of undesirable substances in feed following updated risk assessments

Directive 2002/32/EC of 7 May 2002 of the European Parliament and of the Council on undesirable substances in animal feed is the framework for the EU action on undesirable substances in feed. This framework Directive provides: ⁎that products intended for animal feed may enter for use in the Union from third countries, be put into circulation and/or used in the Union only if they are sound, genuine and of merchantable quality and therefore when correctly used do not represent any danger to human health, animal health or to the environment or could adversely affect livestock production. ⁎that in order to protect animal and public health and the environment, maximum levels for specific undesirable substances shall be established where necessary. ⁎for mandatory consultation of a scientific body (EFSA) for all provisions which may have an effect upon public health or animal health or on the environment. ⁎that products intended for animal feed containing levels of an undesirable substance that exceed the established maximum level may not be mixed for dilution purposes with the same, or other, products intended for animal feed and may not be used for the production of compound feed. Based on the provisions and principles laid down in this framework Directive, maximum levels for a whole range of undesirable substances have been established at EU level. During the discussions in view of the adoption of Directive 2002/32/EC, the European Commission made the commitment to review all existing provisions on undesirable substances on the basis of updated scientific risk assessments. Following requests of the European Commission, the Panel on Contaminants in the Food Chain (CONTAM) from the European Food Safety Authority (EFSA) has completed a series of 30 risk assessments undertaken over the last 5 years on undesirable substances in animal feed reviewing the possible risks for animal and human health due to the presence of these substances in animal feed. EU legislation on undesirable substances has undergone recently several changes to take account of these most recent scientific opinions. Furthermore EFSA has assessed the risks for public and animal health following the unavoidable carry-over of coccidiostats into non target feed. Maximum levels for the unavoidable carry-over have been established for the non-target feed and the food of animal origin from non-target animal species.

54 ENVIRONMENTAL SCIENCES↗

Using dorsal surface for individual identification of dairy calves through 3D deep learning algorithms

Advances in machine learning techniques have allowed the development of computer vision systems (CVS) that can accurately predict several phenotypes of interest for livestock operations. In this context, 3D images taken from a top-down view are particularly useful for estimating body condition score, growth development, and body biometrics in cattle. Frequently, such CVS rely on identification (ID) systems, such as electronic tags, as a way to match animal ID and the predicted phenotype. However, the same 3D images used to predict body weight and other animal biometrics could be adopted for animal recognition as well. Such alternative would optimize CVS to recognize animal ID and monitor growth development simultaneously while leveraging the same hardware infrastructure. Furthermore, this strategy could be used to recognize animals with similar color patterns. Nonetheless, growing animals are continuously changing body shape, which could limit its use as an invariant feature for pattern recognition. Thus, the objectives of this study were: (1) to compare algorithms for different 3D object representations to identify individual animals; and (2) to evaluate how short-term changes in body shape due to animal growth affect the predictive performance of these algorithms. For objective 1, the algorithms were trained (n = 4,558) and tested (n = 1,139) using images from 38 Holstein calves. For objective 2, we designed three different experiments using images (n = 2,347) from five Holstein calves taken over six weeks during their growing period, always training and testing on different weeks. Each experiment evaluated how changing a different parameter of the image capturing procedure affected the predictive ability of the trained algorithms. In the first experiment, we varied the total number of images per animal in the training set; in the second experiment, we varied the number of weeks while keeping a fixed number of images in the training set; and in the third experiment, we skipped weeks between images in the training and test sets. The F 1 score for objective (1) was up to 0.804 when testing with the last frames of each video, and up to 0.959 when using random frames for testing. For objective (2), the F 1 score was up to 0.947 for the first experiment when using 130 images per animal; up to 0.979 for the second experiment when using all five weeks; and up to 0.917 when not skipping weeks between training and testing. In conclusion, these results show that deep learning algorithms can be used to identify individual animals through their dorsal area 3D surfaces, and, from our experiments using calves in their growing period, that they are robust enough to account for changes in body shape and size, making them a promising tool for animal recognition during growth.

3D neural networks↗

The Oral and Skin Microbiomes of Captive Komodo Dragons Are Significantly Shared with Their Habitat

Animals, including humans, have evolved in the context of exposure to a variety of microbial organisms present in the environment. Only recently have humans, and some animals, begun to spend a significant amount of time in enclosed artificial environments, rather than in the more natural spaces in which most of evolution took place. The consequences of this radical change in lifestyle likely extend to the microbes residing in and on our bodies and may have important implications for health and disease. A full characterization of host-microbe sharing in both closed and open environments will provide crucial information that may enable the improvement of health in humans and in captive animals, both of which experience a greater incidence of disease (including chronic illness) than counterparts living under more ecologically natural conditions. Examining the way in which animals, including those in captivity, interact with their environment is extremely important for studying ecological processes and developing sophisticated animal husbandry. Here we use the Komodo dragon (Varanus komodoensis) to quantify the degree of sharing of salivary, skin, and fecal microbiota with their environment in captivity. Both species richness and microbial community composition of most surfaces in the Komodo dragon’s environment are similar to the Komodo dragon’s salivary and skin microbiota but less similar to the stool-associated microbiota. We additionally compared host-environment microbiome sharing between captive Komodo dragons and their enclosures, humans and pets and their homes, and wild amphibians and their environments. We observed similar host-environment microbiome sharing patterns among humans and their pets and Komodo dragons, with high levels of human/pet- and Komodo dragon-associated microbes on home and enclosure surfaces. In contrast, only small amounts of amphibian-associated microbes were detected in the animals’ environments. We suggest that the degree of sharing between the Komodo dragon microbiota and its enclosure surfaces has important implications for animal health. These animals evolved in the context of constant exposure to a complex environmental microbiota, which likely shaped their physiological development; in captivity, these animals will not receive significant exposure to microbes not already in their enclosure, with unknown consequences for their health. Animals, including humans, have evolved in the context of exposure to a variety of microbial organisms present in the environment. Only recently have humans, and some animals, begun to spend a significant amount of time in enclosed artificial environments, rather than in the more natural spaces in which most of evolution took place. The consequences of this radical change in lifestyle likely extend to the microbes residing in and on our bodies and may have important implications for health and disease. A full characterization of host-microbe sharing in both closed and open environments will provide crucial information that may enable the improvement of health in humans and in captive animals, both of which experience a greater incidence of disease (including chronic illness) than counterparts living under more ecologically natural conditions.

59 BASIC BIOLOGICAL SCIENCES↗

Microalgae Commodities from Coal-Fired Power Plant Flue Gas CO 2 (Draft Final Report, October 1, 2015 to June 30, 2018)

The Orlando Utilities Commission (OUC) operates an approximately 900-MWe coal fired-power plant at Stanton Energy Center (SEC), which was the site for this project to develop an integrated process for microalgae utilization of flue gas CO 2 for the production of biofuels and animal feeds. Microalgae have both potentially high yields (tons biomass/acre-year) and can be used for biofuels or high value animal feeds. The high biomass yields of microalgae cultures allows efficient use of land and water resources. They can also use wastewaters, recycle fertilizers, and have lower overall greenhouse gas emissions than conventional biofuels or animal feeds. However, many technical issues and technology gaps related to large-scale algae biomass production still must be resolved before such a process can be scaled-up. In this project, techno-economic analyses (TEAs) and life cycle assessments (LCAs) were carried out, projecting the costs and impacts of large-scale algae biomass cultivation for production of biofuels and animal feeds using OUC-SEC flue gas CO 2 . In addition, 3.5-m 2 (~ 40-ft 2 ) experimental raceway ponds were used for the cultivation of microalgae at OUC-SEC and also at the University of Florida. A large-scale algae farm was designed for a 1,300-acre site (~500-ha) located near the OUC-SEC plant, consisting of 400 hectares (1,000 acres) of paddle wheel mixed raceway ponds (each 4 ha), receiving flue gas piped approximately 3 km (2 miles) from the SEC plant. In the first year of this project (Budget Period 1, BP1), the TEA and LCA studies focused on the production of biogas produced from algae biomass and its use to replace coal at the power plant. However, due to the resulting very high cost of CO 2 mitigation, the process was modified to produce compressed natural gas (‘renewable natural gas’, RNG) for transportation fuel from the biogas, in conjunction with wastewater treatment by the algae cultures. During Budget Period 2 (BP2), the TEA and LCA studies focused on the production of animal feeds by the algae farm, using fresh water and agricultural fertilizers. In this case, CO 2 mitigation costs would be entirely covered if the algal biomass could be sold at between a two to three-fold premium above soybean feed, based on a higher nutritional value for the algal biomass. In support of the above analyses, microalgae cultivation experiments were carried out for over two years during this project in small 3.5-m 2 ponds at both SEC and the University of Florida. The most important results were the demonstration at SEC of the cultivation, on flue gas CO 2 , of filamentous algae biomass, which can be harvested at much lower cost than processes required for the colloidal algae species, as currently used by almost all algal mass culture biofuels and animal feeds projects. The yield of biogas production from the algal biomass was investigated by the University of Florida, and the value of the algal biomass as animal feed was projected based on biochemical analysis of the SEC ad UF biomasses. The conclusion from TEA/LCA carried out for the biogas case in BP1 was that a 400-ha algae system producing biomethane for co-firing at OUC-SEC could generate 27,500 MWh/yr of renewable power, offsetting 28,400 Mg CO 2eq /yr, which amounted to less than 1% of the CO 2 emitted by the SEC plant. (Mg = metric ton = 1.10 short tons). The overall cost was projected at $820/Mg of CO 2eq reduction, making this process unfeasible under any possible scenario. More favorable economics were projected when the biogas was converted to higher value transportation fuel, RNG, which also would benefit from renewable fuel (RINs) and possibly other credits. However, only by combining RNG production with municipal wastewater treatment in the algal ponds would CO 2 utilization result in no net cost or even be economically beneficial (i.e., generate income to the power plant). However, in that case the amount of CO 2 utilization would be even lower than that in the biogas case, because a large fraction of the carbon required would be supplied from the wastewater and CO 2 recovered during biogas upgrading to RNG. In brief, use of power plant CO 2 emissions for algal biofuels production was not favorable, even with optimistic assumptions about biomass productivity and biogas yields. For the animal feed case, developed during BP2, algal biomass would replace soybean feeds. The same scale 400-ha algal production plant was projected to produce 26,280 Mg per year of animal feed with a utilization of 45,300 Mg flue gas CO 2 taken up by the algal biomass. However, the process would result in a projected reduction of 112,500 Mg CO 2eq emissions per year, or roughly 1.9% of OUC-SEC emissions, mainly due to the large CO 2eq emissions from conventional soybean production. A major factor in this analysis were greenhouse gas emissions from land use changes. The cost of CO 2 utilization was projected at $116/Mg if the biomass sold for the same price as soybean meal, but if sold as a premium feed (e.g., based on high omega-3 fatty acid and carotenoid content), the power plant could actually charge for the CO 2 utilized. These economic projections are sensitive to assumptions underlying the TEA and LCA models, including biomass composition and the financial models used to project CAPEX and OPEX. Further development of an algal animal feed production using coal-fired power plant flue gas CO 2 is recommended based on the TEA and LCA, as well as experimental results. The required research and development is detailed in a technology gap analysis (Section 11), which focuses on the demonstrations of the cultivation of higher value filamentous algal biomass at OUC-SEC.

01 COAL, LIGNITE, AND PEAT↗

Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database

The contribution of animal testing in drug development has been widely debated and challenged. An industry-wide nonclinical to clinical translational database was created to determine how safety assessments in animal models translate to First-In-Human clinical risk. The blinded database was composed of 182 molecules and contained animal toxicology data coupled with clinical observations from phase I human studies. Animal and clinical data were categorized by organ system and correlations determined. The 2 × 2 contingency table (true positive, false positive, true negative, false negative) was used for statistical analysis. Sensitivity was 48% with a 43% positive predictive value (PPV). The nonhuman primate had the strongest performance in predicting adverse effects, especially for gastrointestinal and nervous system categories. When the same target organ was identified in both the rodent and nonrodent, the PPV increased. Specificity was 84% with an 86% negative predictive value (NPV). The beagle dog had the strongest performance in predicting an absence of clinical adverse effects. If no target organ toxicity was observed in either test species, the NPV increased. While nonclinical studies can demonstrate great value in the PPV for certain species and organ categories, the NPV was the stronger predictive performance measure across test species and target organs indicating that an absence of toxicity in animal studies strongly predicts a similar outcome in the clinic. These results support the current regulatory paradigm of animal testing in supporting safe entry to clinical trials and provide context for emerging alternate models. - Highlights: • Translational database created to determine animal to human safety concordance. • 182 molecules with animal and clinical data; concordance parameters determined • Positive predictive value of 43%; Negative predictive value of 86% • Absence of toxicity in animal study strongly predicts similar outcome in the clinic. • Database supports animal testing to ensure human safety in the clinic.

60 APPLIED LIFE SCIENCES↗

Update of distillers grains displacement ratios for corn ethanol life-cycle analysis.

Production of corn-based ethanol (either by wet milling or by dry milling) yields the following coproducts: distillers grains with solubles (DGS), corn gluten meal (CGM), corn gluten feed (CGF), and corn oil. Of these coproducts, all except corn oil can replace conventional animal feeds, such as corn, soybean meal, and urea. Displacement ratios of corn-ethanol coproducts including DGS, CGM, and CGF were last updated in 1998 at a workshop at Argonne National Laboratory on the basis of input from a group of experts on animal feeds, including Prof. Klopfenstein (University of Nebraska, Lincoln), Prof. Berger (University of Illinois, Urbana-Champaign), Mr. Madson (Rapheal Katzen International Associates, Inc.), and Prof. Trenkle (Iowa State University) (Wang 1999). Table 1 presents current dry milling coproduct displacement ratios being used in the GREET model. The current effort focuses on updating displacement ratios of dry milling corn-ethanol coproducts used in the animal feed industry. Because of the increased availability and use of these coproducts as animal feeds, more information is available on how these coproducts replace conventional animal feeds. To glean this information, it is also important to understand how industry selects feed. Because of the wide variety of available feeds, animal nutritionists use commercial software (such as Brill Formulation{trademark}) for feed formulation. The software recommends feed for the animal on the basis of the nutritional characteristics, availability, and price of various animal feeds, as well as on the nutritional requirements of the animal (Corn Refiners Association 2006). Therefore, feed formulation considers both the economic and the nutritional characteristics of feed products.

09 BIOMASS FUELS↗

Multi-static Serial LiDAR for Surveillance and Identification of Marine Life at MHK Installations

Final Report for project DE-EE0006787: Multi-static Serial LiDAR for Surveillance and Identification of Marine Life at MHK Installations. This project developed and tested an optical monitoring system prototype that will be suitable for marine and hydrokinetic (MHK) full project lifecycle observation (baseline, commissioning, and decommissioning), with automated real-time classification of marine animals. This system can be deployed to collect pre-installation baseline species observations at a proposed deployment site with minimal post-processing overhead. To satisfy deployed MHK project species of concern (e.g. Endangered Species Act-listed) monitoring requirements, the system provides automated tracking and notification of the presence of managed animals within established perimeters of MHK equipment and provides high resolution imagery of their behavior through a wide range of conditions. During a project’s decommissioning stage, the system can remain installed to provide resource managers with post-installation data. Our technology, known as an Unobtrusive Multi-static Serial LiDAR Imager (UMSLI), is a technology transfer of underwater distributed LiDAR imaging technology that preserves the advantages of traditional optical and acoustic solutions while overcoming associated disadvantages for MHK environmental monitoring applications. This new approach is a purposefully-designed, reconfigurable adaptation of an existing technology that can be easily mounted on or around different classes of MHK equipment. The system uses low average power red (638nm) laser illumination to be invisible and eye-safe to marine animals and is compact and cost effective. The equipment is designed for long term, maintenance-free operations, to inherently generate a sparse primary dataset that only includes detected anomalies (animal presence information), and to allow robust real-time automated animal classification/identification with a low data bandwidth requirement. Advantages of the technology over others currently being used or being considered for MHK monitoring include: Unlike a conventional camera, the depth of field is near-infinite and limited by attenuation (approximately 5-8 m) rather than focal properties of a lens; Operation in an adaptive mode which can project a sparse grid of pulses with higher peak power for longer range detection (>10 meters) and track animals within a zone of interest with high resolution imagery for identification of marine life at closer range (<5m); System detection limit and Signal-to-Noise-Ratio is superior to a camera, due to rejection of both backscattering component and ambient solar background; Multiple wide-angle pulsed laser illuminators and bucket detectors can be flexibly configured to cover a 4pi steradian (i.e. omnidirectional) scene volume, while also retrieving 3D features of animal targets from timing information; Process and classification framework centered around a novel active learning and incremental classification classifier that enables accurate identification of a variety of marine animals automatically; A two-tiered monitoring architecture and invisible watermarking-based data archiving and retrieving approach ensures significant data reduction while preserving high fidelity monitoring. A methodology to train and optimize the classifier for target species of concern to optimize site monitoring effectiveness. This technological innovation addresses a high priority regulatory requirement to observe marine life interaction near MHK projects. Our solution improves resource manager confidence that any interactions between marine animals and equipment are observed in a cost-effective and automated manner. Without EERE funding, this novel application of multi-static LiDAR would not have been available to the MHK community for environmental monitoring.

16 TIDAL AND WAVE POWER↗

Operation and Maintenance of the National Radiobiology Archives

The National Radiobiology Archives (NRA) are an archival program, started in 1989, to collect, organize and maintain data, laboratory notebooks, and animal tissue specimens from government (Department of Energy and its predecessor agencies) sponsored radiobiology life-span animal studies. These unique records, histopathology slides and paraffin embedded tissue blocks are maintained in a central facility and are available for further research study. The materials include electronic and paper records for each of more than 6,000 life-span-observations on dogs as well as details of major studies involving nearly 30,000 mice. Although these studies were performed over many years and at different laboratories with differing data management systems, the NRA has translated them into a standardized set of relational database tables. These can be distributed to interested individuals on written request. Specific Aims are: (1) To Maintain the Archive of Written Records from the Animal Experiments - The USTUR continued to maintain the NRA archives which consist of approximately 175 storage boxes containing laboratory notebooks, animal exposure records, animal pathologic records, and radiographs. These were stored in a 6,000 square foot leased facility in Richland, WA. Additionally, through a collaboration with Pacific Northwest National Laboratory's (PNNL) Low Dose Program, many of these records were scanned into digital files. These totaled 34 GB of data, which are saved in 2,407 separate PDF files that are organized by box number and animal identification number. (2) To Maintain the Archive of Animal Tissues at Washington State University - The USTUR continued to house the NRA dog tissue collection in the leased facility. The NRA tissue collection consisted of pathology slides and tissue blocks. Approximately 25% of the laboratory facility was dedicated to the storage of the NRA materials. (3) To Organize the Datasets of These Animals in the Context of Other Datasets so That They Can be Used by the Scientific Community at Large - As was reported in the FY2009 NRA progress report, Dr. Chuck Watson (NRA Database Consultant) completed his service as the US representative on the European Radiobiological Archives (ERA) Advisory Board during FY2009. Unfortunately, due to the lack of financial support during FY2010, the NRA was not able to make further contributions to the ERA's efforts.

59 BASIC BIOLOGICAL SCIENCES↗

WE-H-206-00: Advances in Preclinical Imaging

Lihong V. Wang: Photoacoustic tomography (PAT), combining non-ionizing optical and ultrasonic waves via the photoacoustic effect, provides in vivo multiscale functional, metabolic, and molecular imaging. Broad applications include imaging of the breast, brain, skin, esophagus, colon, vascular system, and lymphatic system in humans or animals. Light offers rich contrast but does not penetrate biological tissue in straight paths as x-rays do. Consequently, high-resolution pure optical imaging (e.g., confocal microscopy, two-photon microscopy, and optical coherence tomography) is limited to penetration within the optical diffusion limit (∼1 mm in the skin). Ultrasonic imaging, on the contrary, provides fine spatial resolution but suffers from both poor contrast in early-stage tumors and strong speckle artifacts. In PAT, pulsed laser light penetrates tissue and generates a small but rapid temperature rise, which induces emission of ultrasonic waves due to thermoelastic expansion. The ultrasonic waves, orders of magnitude less scattering than optical waves, are then detected to form high-resolution images of optical absorption at depths up to 7 cm, conquering the optical diffusion limit. PAT is the only modality capable of imaging across the length scales of organelles, cells, tissues, and organs (up to whole-body small animals) with consistent contrast. This rapidly growing technology promises to enable multiscale biological research and accelerate translation from microscopic laboratory discoveries to macroscopic clinical practice. PAT may also hold the key to label-free early detection of cancer by in vivo quantification of hypermetabolism, the quintessential hallmark of malignancy. Learning Objectives: To understand the contrast mechanism of PAT To understand the multiscale applications of PAT Benjamin M. W. Tsui: Multi-modality molecular imaging instrumentation and techniques have been major developments in small animal imaging that has contributed significantly to biomedical research during the past decade. The initial development was an extension of clinical PET/CT and SPECT/CT from human to small animals and combine the unique functional information obtained from PET and SPECT with anatomical information provided by the CT in registered multi-modality images. The requirements to image a mouse whose size is an order of magnitude smaller than that of a human have spurred advances in new radiation detector technologies, novel imaging system designs and special image reconstruction and processing techniques. Examples are new detector materials and designs with high intrinsic resolution, multi-pinhole (MPH) collimator design for much improved resolution and detection efficiency compared to the conventional collimator designs in SPECT, 3D high-resolution and artifact-free MPH and sparse-view image reconstruction techniques, and iterative image reconstruction methods with system response modeling for resolution recovery and image noise reduction for much improved image quality. The spatial resolution of PET and SPECT has improved from ∼6–12 mm to ∼1 mm a few years ago to sub-millimeter today. A recent commercial small animal SPECT system has achieved a resolution of ∼0.25 mm which surpasses that of a state-of-art PET system whose resolution is limited by the positron range. More recently, multimodality SA PET/MRI and SPECT/MRI systems have been developed in research laboratories. Also, multi-modality SA imaging systems that include other imaging modalities such as optical and ultrasound are being actively pursued. In this presentation, we will provide a review of the development, recent advances and future outlook of multi-modality molecular imaging of small animals. Learning Objectives: To learn about the two major multi-modality molecular imaging techniques of small animals. To learn about the spatial resolution achievable by the molecular imaging systems for small animal today. To learn about the new multi-modality imaging instrumentation and techniques that are being developed. Sang Hyun Cho; X-ray fluorescence (XRF) imaging, such as x-ray fluorescence computed tomography (XFCT), offers unique capabilities for accurate identification and quantification of metals within the imaging objects. As a result, it has emerged as a promising quantitative imaging modality in recent years, especially in conjunction with metal-based imaging probes. This talk will familiarize the audience with the basic principles of XRF/XFCT imaging. It will also cover the latest development of benchtop XFCT technology. Additionally, the use of metallic nanoparticles such as gold nanoparticles, in conjunction with benchtop XFCT, will be discussed within the context of preclinical multimodal multiplexed molecular imaging. Learning Objectives: To learn the basic principles of XRF/XFCT imaging To learn the latest advances in benchtop XFCT development for preclinical imaging Funding support received from NIH and DOD; Funding support received from GE Healthcare; Funding support received from Siemens AX; Patent royalties received from GE Healthcare; L. Wang, Funding Support: NIH; COI: Microphotoacoustics; S. Cho, Yes: ;NIH/NCI grant R01CA155446 DOD/PCRP grant W81XWH-12-1-0198.

60 APPLIED LIFE SCIENCES↗

WE-H-206-01: Photoacoustic Tomography: Multiscale Imaging From Organelles to Patients by Ultrasonically Beating the Optical Diffusion Limit

Lihong V. Wang: Photoacoustic tomography (PAT), combining non-ionizing optical and ultrasonic waves via the photoacoustic effect, provides in vivo multiscale functional, metabolic, and molecular imaging. Broad applications include imaging of the breast, brain, skin, esophagus, colon, vascular system, and lymphatic system in humans or animals. Light offers rich contrast but does not penetrate biological tissue in straight paths as x-rays do. Consequently, high-resolution pure optical imaging (e.g., confocal microscopy, two-photon microscopy, and optical coherence tomography) is limited to penetration within the optical diffusion limit (∼1 mm in the skin). Ultrasonic imaging, on the contrary, provides fine spatial resolution but suffers from both poor contrast in early-stage tumors and strong speckle artifacts. In PAT, pulsed laser light penetrates tissue and generates a small but rapid temperature rise, which induces emission of ultrasonic waves due to thermoelastic expansion. The ultrasonic waves, orders of magnitude less scattering than optical waves, are then detected to form high-resolution images of optical absorption at depths up to 7 cm, conquering the optical diffusion limit. PAT is the only modality capable of imaging across the length scales of organelles, cells, tissues, and organs (up to whole-body small animals) with consistent contrast. This rapidly growing technology promises to enable multiscale biological research and accelerate translation from microscopic laboratory discoveries to macroscopic clinical practice. PAT may also hold the key to label-free early detection of cancer by in vivo quantification of hypermetabolism, the quintessential hallmark of malignancy. Learning Objectives: To understand the contrast mechanism of PAT To understand the multiscale applications of PAT Benjamin M. W. Tsui: Multi-modality molecular imaging instrumentation and techniques have been major developments in small animal imaging that has contributed significantly to biomedical research during the past decade. The initial development was an extension of clinical PET/CT and SPECT/CT from human to small animals and combine the unique functional information obtained from PET and SPECT with anatomical information provided by the CT in registered multi-modality images. The requirements to image a mouse whose size is an order of magnitude smaller than that of a human have spurred advances in new radiation detector technologies, novel imaging system designs and special image reconstruction and processing techniques. Examples are new detector materials and designs with high intrinsic resolution, multi-pinhole (MPH) collimator design for much improved resolution and detection efficiency compared to the conventional collimator designs in SPECT, 3D high-resolution and artifact-free MPH and sparse-view image reconstruction techniques, and iterative image reconstruction methods with system response modeling for resolution recovery and image noise reduction for much improved image quality. The spatial resolution of PET and SPECT has improved from ∼6–12 mm to ∼1 mm a few years ago to sub-millimeter today. A recent commercial small animal SPECT system has achieved a resolution of ∼0.25 mm which surpasses that of a state-of-art PET system whose resolution is limited by the positron range. More recently, multimodality SA PET/MRI and SPECT/MRI systems have been developed in research laboratories. Also, multi-modality SA imaging systems that include other imaging modalities such as optical and ultrasound are being actively pursued. In this presentation, we will provide a review of the development, recent advances and future outlook of multi-modality molecular imaging of small animals. Learning Objectives: To learn about the two major multi-modality molecular imaging techniques of small animals. To learn about the spatial resolution achievable by the molecular imaging systems for small animal today. To learn about the new multi-modality imaging instrumentation and techniques that are being developed. Sang Hyun Cho; X-ray fluorescence (XRF) imaging, such as x-ray fluorescence computed tomography (XFCT), offers unique capabilities for accurate identification and quantification of metals within the imaging objects. As a result, it has emerged as a promising quantitative imaging modality in recent years, especially in conjunction with metal-based imaging probes. This talk will familiarize the audience with the basic principles of XRF/XFCT imaging. It will also cover the latest development of benchtop XFCT technology. Additionally, the use of metallic nanoparticles such as gold nanoparticles, in conjunction with benchtop XFCT, will be discussed within the context of preclinical multimodal multiplexed molecular imaging. Learning Objectives: To learn the basic principles of XRF/XFCT imaging To learn the latest advances in benchtop XFCT development for preclinical imaging Funding support received from NIH and DOD; Funding support received from GE Healthcare; Funding support received from Siemens AX; Patent royalties received from GE Healthcare; L. Wang, Funding Support: NIH; COI: Microphotoacoustics; S. Cho, Yes: ;NIH/NCI grant R01CA155446 DOD/PCRP grant W81XWH-12-1-0198.

60 APPLIED LIFE SCIENCES↗